GlaxoSmithKline said net profit fell in the first quarter of 2016, due to a tough year-earlier comparison that had been boosted by proceeds from its Novartis deal, without that effect, profit rose on cost savings from the same deal.
from WSJ.com: US Business http://ift.tt/1WSyQZV
via IFTTT
No comments:
Post a Comment